GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » Cyclically Adjusted Revenue per Share

BioGaia AB (LTS:0GTN) Cyclically Adjusted Revenue per Share : kr10.48 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

BioGaia AB's adjusted revenue per share for the three months ended in Mar. 2025 was kr3.621. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr10.48 for the trailing ten years ended in Mar. 2025.

During the past 12 months, BioGaia AB's average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of BioGaia AB was 12.90% per year. The lowest was 10.30% per year. And the median was 11.10% per year.

As of today (2025-05-27), BioGaia AB's current stock price is kr103.27458. BioGaia AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr10.48. BioGaia AB's Cyclically Adjusted PS Ratio of today is 9.85.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of BioGaia AB was 18.84. The lowest was 9.18. And the median was 13.06.


BioGaia AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for BioGaia AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Cyclically Adjusted Revenue per Share Chart

BioGaia AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.82 7.44 8.69 9.80 10.57

BioGaia AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.92 10.22 10.35 10.57 10.48

Competitive Comparison of BioGaia AB's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Cyclically Adjusted PS Ratio falls into.


;
;

BioGaia AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioGaia AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.621/132.8245*132.8245
=3.621

Current CPI (Mar. 2025) = 132.8245.

BioGaia AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1.547 99.995 2.055
201509 1.220 100.228 1.617
201512 1.199 100.276 1.588
201603 1.544 100.751 2.036
201606 1.566 101.019 2.059
201609 1.452 101.138 1.907
201612 1.599 102.022 2.082
201703 1.626 102.022 2.117
201706 1.799 102.752 2.326
201709 1.703 103.279 2.190
201712 1.963 103.793 2.512
201803 1.808 103.962 2.310
201806 2.062 104.875 2.612
201809 2.016 105.679 2.534
201812 2.811 105.912 3.525
201903 1.977 105.886 2.480
201906 2.563 106.742 3.189
201909 1.924 107.214 2.384
201912 2.316 107.766 2.855
202003 2.111 106.563 2.631
202006 2.799 107.498 3.458
202009 1.508 107.635 1.861
202012 1.970 108.296 2.416
202103 2.000 108.360 2.452
202106 2.005 108.928 2.445
202109 1.711 110.338 2.060
202112 2.047 112.486 2.417
202203 2.811 114.825 3.252
202206 2.853 118.384 3.201
202209 2.552 122.296 2.772
202212 2.716 126.365 2.855
202303 3.623 127.042 3.788
202306 3.122 129.407 3.204
202309 3.146 130.224 3.209
202312 2.949 131.912 2.969
202403 3.662 132.205 3.679
202406 3.803 132.716 3.806
202409 3.007 132.304 3.019
202412 3.606 132.987 3.602
202503 3.621 132.825 3.621

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


BioGaia AB  (LTS:0GTN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BioGaia AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=103.27458/10.48
=9.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of BioGaia AB was 18.84. The lowest was 9.18. And the median was 13.06.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


BioGaia AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB Headlines

No Headlines